Citigroup
PLXP

Citigroup’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Citigroup’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,798
Closed -$38K – 6763
2021
Q4 		$38K Buy
4,798
+2,770
+137% +$32.5K ﹤0.01% 5199
2021
Q3 		$39K Buy
+2,028
New +$35.4K ﹤0.01% 4884
2016
Q2 		– Sell
-6
Closed – – 7547
2016
Q1 		$0 Buy
+6
New +$381 ﹤0.01% 7867
2015
Q3 		– Sell
-30
Closed -$3K – 7836
2015
Q2 		$3K Buy
+30
New +$3.1K ﹤0.01% 7041
2014
Q4 		– Sell
-25
Closed -$2K – 7386
2014
Q3 		$2K Buy
+25
New +$1.91K ﹤0.01% 6831

Other funds holding PLXP

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

Citigroup's PLXP Position: Q1 2022 in Review

Citigroup sold out of PLx Pharma Inc. Common Stock (PLXP) in Q1 2022, closing a stake of 4,798 shares — an estimated $38K sold.

Citigroup first reported a position in PLXP in Q3 2014 and held it in 5 quarters. The position peaked at $39K in Q3 2021. 50 funds tracked by Wall St. Rank hold PLXP as of Q1 2022.

  • Citigroup reported no remaining PLx Pharma Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Citigroup sold 4,798 PLx Pharma Inc. Common Stock shares in Q1 2022, an estimated $38K.
  • Citigroup first reported a position in PLx Pharma Inc. Common Stock in Q3 2014 and held it in 5 quarters.
  • Citigroup's PLx Pharma Inc. Common Stock position peaked at $39K in Q3 2021.
  • 50 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q1 2022.

Based on Citigroup's 13F filing for Q1 2022, filed 12 May 2022.